Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 165
Selected: 0
NCT IDTitle
NCT07612488A Study of CS231295 in Patients With Advanced Solid Tumors
NCT02573896Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
NCT01750684AC105 in Patients With Acute Traumatic Spinal Cord Injury
NCT07116681Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pulmonary Hypertension
NCT01104870A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension
NCT00262106Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
NCT00159250Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
NCT01027949An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension
NCT04050449Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD
NCT01746485Three Times Daily Dosing of UT-15C
NCT01028651A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
NCT02893995Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension
NCT00705133Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension
NCT02074449Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)
NCT05776225Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
NCT02603068Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
NCT00887978Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension
NCT05060315Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin
NCT04865393Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function
NCT00741819Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects
NCT01477333Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
NCT04005469Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
NCT00775463Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine
NCT03043651Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF
NCT03794583Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
NCT01131845The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil
NCT03098030Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer
NCT02663895Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis
NCT05255991Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
NCT06425796Adiposity and Iron Requirements in Pregnancy
NCT04712266A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes
NCT01447407Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine
NCT03012646Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD
NCT01260454The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain
NCT02583789Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon
NCT04411680Study of Sargramostim in Patients With COVID-19
NCT02318758Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunteers
NCT01557647Safety and Efficacy of Inhaled Treprostinil in Patients With PAH
NCT073912155G-PEARL: Paxalisib in Malignant Brain Tumours
NCT05848687TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
NCT02261883Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
NCT01494896Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
NCT06878560Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
NCT04868292Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 in Healthy Volunteers
NCT04341948Treatment of Post-Operative Pain Following Orthopedic Surgery With SPRINT® Peripheral Nerve Stimulation (PNS) System
NCT04707664Sargramostim Use in COVID-19 to Recover Patient Health
NCT02882126An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension
NCT01153386Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine
NCT01560637An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
NCT00494533Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension